Skip to main content

Table 4 Administered beta-lactams at admission for patients with or without different macrolides and fluoroquinolones

From: Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial

  Azithromycin
(N = 151)
Clarithromycin
(N = 222)
Erythromycin
(N = 277)
Ciprofloxacin
(N = 206)
Levofloxacin
(N = 194)
Moxifloxacin
(N = 554)
No macrolides or fluoroquinolones
(N = 587)
Amoxicillin 17 (11.0%) 53 (22.3%) 25 (8.4%) 70 (34.0%) 2 (1.0%) 16 (2.9%) 149 (25.4%)
Amoxicillin/clavulanic acid 37 (23.9%) 148 (62.2%) 33 (11.1%) 69 (33.5%) 6 (3.1%) 18 (3.2%) 291 (49.6%)
Ceftriaxone 72 (46.5%) 17 (7.1%) 31 (10.4%) 30 (14.6%) 4 (2.1%) 28 (5.1%) 95 (16.2%)
Cefuroxime 5 (3.2%) 12 (5.0%) 96 (32.2%) 10 (4.9%) 0 (0.0%) 3 (0.5%) 24 (4.1%)
Cefotaxime 0 (0.0%) 1 (0.4%) 3 (1.0%) 1 (0.5%) 0 (0.0%) 0 (0.0%) 1 (0.2%)
Ceftazidime 4 (2.6%) 2 (0.8%) 3 (1.0%) 8 (3.9%) 1 (0.5%) 1 (0.2%) 12 (2.0%)
Penicillin 5 (3.2%) 10 (4.2%) 146 (49.0%) 20 (9.7%) 8 (4.1%) 10 (1.8%) 9 (1.5%)
  1. Values are numbers (column percentages) unless otherwise noted